Leaflet RAPIBLOC 20mg / 2ml concentrate for solution for injection

Product code:: W66025001
Quantity:: 5
Indicated for:: cardiac arrhythmias
Route of administration:: injectable
Substance:: landiolol (antiarrhythmic)
ATC: C07AB14 — Cardiovascular system | Beta blocking agents | Beta blocking agents | Beta blocking agents, selective

Precautions:

Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Landiolol is a medication used to control supraventricular tachycardia and perioperative hypertension. It is an ultra-selective beta-blocker with rapid action that reduces heart rate and blood pressure by blocking beta-1 adrenergic receptors.

The medication is administered intravenously, usually in a hospital setting, under the supervision of a doctor. Due to its rapid onset and short duration of effect, it is ideal for use in acute situations.

Side effects may include low blood pressure, bradycardia, dizziness, or nausea. In rare cases, severe allergic reactions or heart failure may occur.

Patients should inform their doctor about any other medications they are taking and be closely monitored during treatment. Pregnant or breastfeeding women should consult a specialist before use.

General data about RAPIBLOC 20mg / 2ml

Substance:: landiolol
Date of latest medicines list:: 01-06-2026
Product code:: W66025001
Concentration:: 20mg / 2ml
Pharmaceutical form:: concentrate for solution for injection
Quantity:: 5
Product type:: Original
Price:: 1004.98 RON
Prescription status:: P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:: AMOMED PHARMA GMBH - AUSTRIA
Holder:: AMOMED PHARMA GMBH - AUSTRIA
Number:: 14035/2021/01
Shelf life:: 18 months-after packing for marketing;after the first opening a fiolei-it is used immediately

Pharmaceutical forms available for landiolol

Concentrations available for landiolol

20mg/2ml
300mg
600mg